Search for:
Examples (hovertap for more info):
term
, -term
, /r/subreddit
, -/r/subreddit
, site:example.com
, -site:example.com
, score:3
, before:2015-03-15
, after:2015-03-15
Sort by:
newest
oldest
top
/r/portlandoregon,
Osimertinib Combo Lessens CNS Progression in EGFR NSCLC 2
/r/lungcancersupport, 2023-10-24, 12:39:56
Sunvozertinib Yields Tolerability, Efficacy in EGFR+ NSCLC 1
/r/lungcancersupport, 2023-06-17, 13:15:32
Data Support ctDNA-Based Adaptive Strategies for EGFR+ Advanced NSCLC 2
/r/nsclc, 2023-06-09, 23:17:02
It's a slow search... To stay in the know, Set an alert
Nivolumab Combo Yields Durable Survival Benefit in Metastatic NSCLC 1
/r/lungcancersupport, 2023-06-06, 21:16:17
PD-1/TIGIT Bispecific Has Preliminary Activity in Previously Treated NSCLC 1
/r/lungcancersupport, 2023-06-05, 21:06:07
Gene Therapy/Osimertinib NSCLC Trial Advances to Phase 2 Expansion 1
/r/lungcancersupport, 2023-06-02, 20:51:38
Olaparib/Durvalumab Fails to Improve DCR, Potentially Improves Survival in SCLC 1
/r/lungcancersupport, 2023-05-26, 21:03:22
WATCH: Clinical Implications of Real-World Amivantamab Data in NSCLC 1
/r/lungcancersupport, 2023-05-07, 13:35:45
FDA Approves FoundationOne Liquid CDx for Mobocertinib in NSCLC 1
/r/lungcancersupport, 2023-05-05, 14:17:52
Novel Telomere-Targeting Combo Demonstrates Safety in Advanced NSCLC 2
/r/nsclc, 2023-05-05, 01:16:42
SCLC Prognosis Remains ‘Unsatisfactory’ Despite Numerous Treatment Options 1
/r/lungcancersupport, 2023-05-03, 18:05:07
ASTRO/ESTRO Guideline Touch on Local Therapy in Oligometastatic NSCLC 2
/r/nsclc, 2023-05-02, 01:55:50
Low/Moderate IRAEs Correlate With Atezolizumab Efficacy in Advanced NSCLC 1
/r/lungcancersupport, 2023-04-22, 12:49:04
Mechanism of Action of BTK Inhibitors in Chronic Lymphocytic Leukemia [VIDEO SERIES 1 of 12] 2
/r/cll, 2023-03-25, 16:27:08
Demographic Factors May Impact Pain Management Referrals in SCLC/NSCLC 2
/r/nsclc, 2023-03-17, 23:49:42
FDA Expands VENTANA PD-L1 Assay Label for Cemiplimab in NSCLC Subtype 2
/r/nsclc, 2023-03-07, 12:51:08
Noninvasive Colon Cancer Screening Test Elicits Notable Sensitivity/Specificity Outcomes 1
/r/portlandoregon,
NSFW
2023-01-14, 00:49:05
Zilovertamab Plus Ibrutinib Yields Promising Responses and PFS in MCL and CLL 1
/r/cll, 2023-01-01, 21:22:00
Cabozantinib/Atezolizumab Fails to Reach Survival End Point But Is Safe in Metastatic NSCLC 2
/r/nsclc, 2022-12-17, 21:30:18
Query breakdown by subreddit posts
API examples
Posts:
Comments:
For more information, see the API Reference page.
curl "https://socialgrep.com/api/v1/search/posts?query=site%3Acancernetwork.com" -H "Accept: application/json" -H "Authorization: Bearer YOUR_KEY"
Comments:
curl "https://socialgrep.com/api/v1/search/comments?query=site%3Acancernetwork.com" -H "Accept: application/json" -H "Authorization: Bearer YOUR_KEY"
For more information, see the API Reference page.
Query breakdown by subreddit posts
API examples
Posts:
Comments:
For more information, see the API Reference page.
curl "https://socialgrep.com/api/v1/search/posts?query=site%3Acancernetwork.com" -H "Accept: application/json" -H "Authorization: Bearer YOUR_KEY"
Comments:
curl "https://socialgrep.com/api/v1/search/comments?query=site%3Acancernetwork.com" -H "Accept: application/json" -H "Authorization: Bearer YOUR_KEY"
For more information, see the API Reference page.